Reducing mortality from 2019-nCoV: host-directed therapies should be an option
The number of confirmed cases of the 2019 novel coronavirus (2019-nCoV) reported to
WHO continues to rise worldwide. 1 As with two other WHO Blueprint priority coronaviruses …
WHO continues to rise worldwide. 1 As with two other WHO Blueprint priority coronaviruses …
[PDF][PDF] Reducing mortality from 2019-nCoV: host-directed therapies should be an option
A Zumla, DS Hui, EI Azhar, ZA Memish, M Maeurer - Lancet, 2020 - discovery.ucl.ac.uk
The Lancet Correspondence Page 1 1 The Lancet Correspondence Title: Reducing
mortality from 2019-nCoV: host-directed therapies should be an option Authors: Alimuddin …
mortality from 2019-nCoV: host-directed therapies should be an option Authors: Alimuddin …
[PDF][PDF] Reducing mortality from 2019-nCoV: host-directed therapies should be an option
A Zumla, DS Hui, EI Azhar, ZA Memish, M Maeurer - medicine, 2019 - clas.cas.cn
The number of confirmed cases of the 2019 novel coronavirus (2019-nCoV) reported to
WHO continues to rise worldwide. 1 As with two other WHO Blueprint priority coronaviruses …
WHO continues to rise worldwide. 1 As with two other WHO Blueprint priority coronaviruses …
Reducing mortality from 2019-nCoV: host-directed therapies should be an option.
A Zumla, DS Hui, EI Azhar, ZA Memish, M Maeurer - 2020 - cabidigitallibrary.org
The objective of the article was to describe the possible treatment modalities for COVID-19.
Specific drugs to treat 2019-nCoV will take several years to develop and evaluate. In the …
Specific drugs to treat 2019-nCoV will take several years to develop and evaluate. In the …
[HTML][HTML] Reducing mortality from 2019-nCoV: host-directed therapies should be an option
A Zumla, DS Hui, EI Azhar, ZA Memish… - Lancet (London …, 2020 - ncbi.nlm.nih.gov
The number of confirmed cases of the 2019 novel coronavirus (2019-nCoV) reported to
WHO continues to rise worldwide. 1 As with two other WHO Blueprint priority coronaviruses …
WHO continues to rise worldwide. 1 As with two other WHO Blueprint priority coronaviruses …
[引用][C] Reducing mortality from 2019-nCoV: host-directed therapies should be an option
A Zumla, DS Hui, E Azhar, ZA Memish, M Maeurer - The Lancet, 2020 - ksascholar.dri.sa
Reducing mortality from 2019-nCoV: host-directed therapies should be an option — Ministry
of Education - Saudi Arabia Skip to main navigation Skip to search Skip to main content …
of Education - Saudi Arabia Skip to main navigation Skip to search Skip to main content …
[PDF][PDF] Reducing mortality from 2019-nCoV: host-directed therapies should be an option
A Zumla, DS Hui, EI Azhar, ZA Memish, M Maeurer - medicine, 2019 - alatorax.org
The number of confirmed cases of the 2019 novel coronavirus (2019-nCoV) reported to
WHO continues to rise worldwide. 1 As with two other WHO Blueprint priority coronaviruses …
WHO continues to rise worldwide. 1 As with two other WHO Blueprint priority coronaviruses …
[PDF][PDF] Reducing mortality from 2019-nCoV: host-directed therapies should be an option
A Zumla, DS Hui, EI Azhar, ZA Memish, M Maeurer - medicine, 2019 - med.uminho.pt
The number of confirmed cases of the 2019 novel coronavirus (2019-nCoV) reported to
WHO continues to rise worldwide. 1 As with two other WHO Blueprint priority coronaviruses …
WHO continues to rise worldwide. 1 As with two other WHO Blueprint priority coronaviruses …
Reducing mortality from 2019-nCoV: host-directed therapies should be an option
A Zumla, DS Hui, EI Azhar… - Lancet (London …, 2020 - pubmed.ncbi.nlm.nih.gov
Reducing mortality from 2019-nCoV: host-directed therapies should be an option Reducing
mortality from 2019-nCoV: host-directed therapies should be an option Lancet. 2020 Feb 22;395(10224):e35-e36 …
mortality from 2019-nCoV: host-directed therapies should be an option Lancet. 2020 Feb 22;395(10224):e35-e36 …
Reducing mortality from 2019-nCoV: host-directed therapies should be an option.
A Zumla, DS Hui, EI Azhar, ZA Memish… - Lancet (London …, 2020 - europepmc.org
The number of confirmed cases of the 2019 novel coronavirus (2019-nCoV) reported to
WHO continues to rise worldwide. 1 As with two other WHO Blueprint priority coronaviruses …
WHO continues to rise worldwide. 1 As with two other WHO Blueprint priority coronaviruses …